The experience of living with malignant meningioma.

Everyday life Malignant meningioma Qualitative research WHO grade 3 meningioma

Journal

Palliative & supportive care
ISSN: 1478-9523
Titre abrégé: Palliat Support Care
Pays: England
ID NLM: 101232529

Informations de publication

Date de publication:
24 May 2023
Historique:
medline: 24 5 2023
pubmed: 24 5 2023
entrez: 24 5 2023
Statut: aheadofprint

Résumé

Meningiomas are the most common, primary intracranial tumor and most are benign. Little is known of the rare patient group living with a malignant meningioma, comprising 1-3% of all meningiomas. Our aim was to explore how patients perceived quality of daily life after a malignant meningioma diagnosis. This qualitative explorative study was composed of individual semi-structured interviews. Eligible patients ( Eight patients were interviewed. The analysis revealed 4 overarching themes: (1) perceived illness and cause of symptoms, (2) identity, roles, and interaction, (3) threat and uncertainty of the future, and (4) belief in authority. The perceived quality of daily life is negatively impacted by the disease. Patients experience a shift in self-concept and close interactions, and some struggle with accepting a new everyday life. Patients have a high risk of discordant prognostic awareness in relation to health-care professionals. We provide a much-needed patient-centered perspective of living with malignant meningioma: quality of life was affected by perception of threat and an uncertainty of the future. Perception of illness and the interpretation of the cause of symptoms varied between subjects, but a common trait was that patients' identity, roles, and interactions were affected. Shared decision-making and a strengthened continuity during follow-up could aid this rare patient group.

Identifiants

pubmed: 37221880
doi: 10.1017/S1478951523000585
pii: S1478951523000585
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Subventions

Organisme : Kræftens Bekæmpelse
ID : R278-A16459
Organisme : Lundbeckfonden
ID : R266-2017-4029

Auteurs

Andrea Daniela Maier (AD)

Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark.

Sara Nordentoft (S)

Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark.

Tiit Mathiesen (T)

Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Rikke Guldager (R)

Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark.

Classifications MeSH